Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Care Twentyone's revenue for the
six
months ended in Apr. 2026 was 円24,803 Mil.
Its revenue for the trailing twelve months (TTM) ended in Apr. 2026 was 円49,347 Mil.
Care Twentyone's Revenue per Share for the
six
months ended in Apr. 2026 was 円1,835.33.
Its Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 was 円3,652.09.
During the past 12 months, the average Revenue per Share Growth Rate of Care Twentyone was 4.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 7.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 7.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 9.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Care Twentyone's highest 3-Year average Revenue per Share Growth Rate was 28.40% per year. The lowest was 6.70% per year. And the median was 11.90% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Care Twentyone Revenue Related Terms
Care Twentyone Revenue Historical Data
* Premium members only.
The historical data trend for Care Twentyone's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Care Twentyone's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Care Twentyone Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Care Twentyone's Revenue distribution charts can be found below:
* The bar in red indicates where Care Twentyone's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Apr. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円49,347 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Care Twentyone (TSE:2373) has a Revenue of 円49,347 Mil as of Apr. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Care Twentyone and its competitors.
Is Care Twentyone's Revenue too high?
Care Twentyone's current Revenue is 円49,347 Mil. Overall, Care Twentyone has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Care Twentyone's Revenue compare to HCA and THC?
Care Twentyone's Revenue of 円49,347 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Care Twentyone and its competitors. Care Twentyone's current Revenue is 円49,347 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Care Twentyone stock overvalued right now?
Based on GuruFocus' analysis, Care Twentyone (TSE:2373) is currently considered Modestly Undervalued. The stock's GF Value™ is 円482.84, compared to a current price of 円403.00 — trading 16.5% below its estimated fair value. The current Revenue is 円49,347 Mil. Care Twentyone's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Care Twentyone (TSE:2373), the current Revenue is 円49,347 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Care Twentyone (TSE:2373) Overvalued in 2026?
Based on GuruFocus' analysis, Care Twentyone stock appears to be undervalued.
The current stock price of 円403.00 is trading 16.5% below its estimated GF Value™ of 円482.84.
GuruFocus considers Care Twentyone to be Modestly Undervalued.
Key valuation signals for TSE:2373:
Revenue: 円49,347 Mil
GF Value™: 円482.84 vs. price of 円403.00 (16.5% below fair value)
No single metric tells the full story. See the TSE:2373 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Care Twentyone Corp provides nursing care services. It also leases and sells nursing equipment as well as operates a nursing home for the elder people. It also provides daycare homes, nursing homes, and group homes. It is also engaged in small-scale multifunctional home care, welfare equipment sales, rental and housing repair and light work contracting business. The company has two reportable segments based on its business model: In-home nursing care business; and Facility-based nursing care business. The home care business provides visiting care services, home care support services, day care services, etc. The Facility-based Nursing Care Business operates paid nursing homes and group homes.
60GF Score
Get the complete analysis for TSE:2373
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2373 has been successfully added to your 
